During the open enrollment period, it is extremely important that Medicare beneficiaries review their prescription coverage ...

The agency announced moves to cut regulatory obstacles for the makers of biosimilar drugs, which are akin to generics and may ...

FRIDAY, Oct. 31, 2025 (HealthDay News) — The U.S. Food and Drug Administration (FDA) announced Wednesday that it will relax ...

To discourage price hikes on brand-name drugs, the IRA requires manufacturers to pay inflation rebates to Medicare if prices ...

The U.S. Food and Drug Administration announced it will relax certain rules for approving low-cost versions of some high-priced medications to reduce costs.

President Donald Trump’s top health advisers announced a push to cut health costs by bringing more cutting-edge generic drugs ...

For decades, the agency has redacted drug names from reports. Now, several former officials support ending the practice.

For those paying the full cost of medications, the new model will reduce the monthly cost for brand-name prescriptions by an ...

With cold and flu season approaching, a neighborhood pharmacist reveals how to save 40% or more on medications. From ...

If you take cholesterol-lowering drugs called statins, you may have noticed a flurry of news coverage since late October 2025 ...

The FDA has revealed a set of measures designed to increase the availability of biosimilars in the U.S. and in turn reduce ...

The US Food and Drug Administration said Wednesday it would ease the approvals process for developing replicas of biologic drugs used to treat conditions including autoimmune diseases, cancer and ...